Ubs Group Ag Maravai Lifesciences Holdings, Inc. Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 555,453 shares of MRVI stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

555,453

Previous 1,951,143 71.53%

Holding current value

$1.48 Million

Previous $10.6 Million 88.46%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$2.21 - $6.13 $3.08 Million - $8.56 Million	-1,395,690 Reduced 71.53%	555,453 $1.23 Million
Q4 2024 Feb 14, 2025	BUY	$4.42 - $8.5 $7.59 Million - $14.6 Million	1,717,771 Added 736.07%	1,951,143 $10.6 Million
Q3 2024 Nov 14, 2024	BUY	$6.84 - $9.73 $453,827 - $645,575	66,349 Added 39.72%	233,372 $1.94 Million
Q2 2024 Aug 13, 2024	BUY	$6.87 - $11.34 $528,680 - $872,669	76,955 Added 85.44%	167,023 $1.2 Million
Q1 2024 May 13, 2024	SELL	$5.11 - $8.76 $324,101 - $555,603	-63,425 Reduced 41.32%	90,068 $780,000
Q4 2023 Feb 09, 2024	BUY	$4.7 - $9.87 $452,219 - $949,661	96,217 Added 167.99%	153,493 $1.01 Million
Q3 2023 Nov 09, 2023	SELL	$9.14 - $12.85 $769,514 - $1.08 Million	-84,192 Reduced 59.51%	57,276 $572,000
Q2 2023 Aug 11, 2023	BUY	$12.09 - $15.0 $333,974 - $414,360	27,624 Added 24.26%	141,468 $1.76 Million
Q1 2023 May 12, 2023	BUY	$12.99 - $16.48 $300,718 - $381,512	23,150 Added 25.53%	113,844 $1.59 Million
Q4 2022 Feb 08, 2023	BUY	$12.5 - $24.78 $84,200 - $166,918	6,736 Added 8.02%	90,694 $1.3 Million
Q3 2022 Nov 10, 2022	SELL	$20.6 - $30.37 $188,922 - $278,523	-9,171 Reduced 9.85%	83,958 $2.14 Million
Q2 2022 Aug 10, 2022	SELL	$26.05 - $37.48 $213,636 - $307,373	-8,201 Reduced 8.09%	93,129 $2.65 Million
Q1 2022 May 16, 2022	SELL	$24.46 - $40.92 $496,586 - $830,757	-20,302 Reduced 16.69%	101,330 $3.57 Million
Q4 2021 Feb 14, 2022	SELL	$35.0 - $45.94 $614,390 - $806,430	-17,554 Reduced 12.61%	121,632 $5.1 Million
Q3 2021 Nov 15, 2021	SELL	$36.8 - $60.62 $422,500 - $695,978	-11,481 Reduced 7.62%	139,186 $6.83 Million
Q2 2021 Aug 13, 2021	BUY	$32.46 - $45.0 $2.61 Million - $3.62 Million	80,369 Added 114.33%	150,667 $6.29 Million
Q1 2021 May 12, 2021	BUY	$25.8 - $38.49 $888,113 - $1.32 Million	34,423 Added 95.95%	70,298 $2.51 Million
Q4 2020 Feb 11, 2021	BUY	$24.5 - $30.86 $878,937 - $1.11 Million	35,875 New	35,875 $1.01 Million

Others Institutions Holding MRVI

# of Institutions

208

Shares Held

129M

Call Options Held

267K

Put Options Held

648K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $351M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account